“…Therefore, the fact that a subsidiary of a Danish company, based in another country, does not violate Section 3 of the Act user countries to control compliance with domestic legislation on PIC and TK, respectively Articles 15 and 16 of the Protocol. 46 On the relationship between the provisions of CBD on access to genetic resources and the Protocol, see Koester, "The Nagoya Protocol on ABS," 17-18. 47 The author, in general, refrains from suggesting amendments of the unofficial translation of the Danish ABS Act provided by the Danish Nature Agency.…”